Daiichi Sankyo Europe GmbH

Featured Stories

At Daiichi Sankyo we can draw upon our rich legacy. Our experience – more than 100 years of innovation – helps us to deliver promising new medicines to patients as shown in our corporate video. read more...

For the last seven years Daiichi Sankyo has supported young graduates in Pharmaceutical Sciences from the Ludwig-Maximilians-University in Munich (LMU). In 2015 Alexander Reim was awarded the "Master Prize" read more...

Featured News

Date	Description
05-31-2016 Research	Daiichi Sankyo Provides Update on Her3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC)	PDF
10-13-2015 Company	Daiichi Sankyo Partners With World Thrombosis Day	PDF
09-23-2015 Products	UK’s NICE recommends once-daily LIXIANA® (edoxaban) for preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation	PDF
09-03-2015 Products	Target 70%: At ESC Congress 2015 Experts Discussed French, Italian and Austrian Initiatives for Better Blood Pressure Control	PDF
08-26-2015 Products	UK’s NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults	PDF
show all

Dear User, This website provides you with information only for healthcare professionals. According to the drug promotion code, we are only able to allow healthcare professionals like physicians and pharmacists to have full access to our website. To visit our page please login.

Daiichi Sankyo
Doc Check

100 Years of Innovation

Support for Young Talents